Navigation Links
Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
Date:9/17/2009

%) and placebo (4.6%).

Conference Call & Webcast

Arena will host a conference call and webcast presentation to discuss the results at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time) on September 18, 2009. Jack Lief, President and Chief Executive Officer; Dominic P. Behan, Ph.D., Senior Vice President and Chief Scientific Officer; William R. Shanahan, M.D., Vice President and Chief Medical Officer; and Christen M. Anderson, M.D., Ph.D., Vice President, Clinical Development, will host the conference call and webcast.

The conference call may be accessed by dialing 888.312.3047 for domestic callers and 719.325.2234 for international callers. Please specify to the operator that you would like to join the "Lorcaserin BLOSSOM Trial Results" conference call. The conference call and slide presentation will be webcast live under the investor relations section of Arena's website at www.arenapharm.com, and will be archived there for 30 days following the call. Please connect to Arena's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

BLOSSOM Trial Design

BLOSSOM is a double-blind, randomized, placebo-controlled trial that enrolled 4,008 patients in approximately 100 sites in the US. The trial evaluated 10 mg of lorcaserin dosed once or twice daily versus placebo over a one-year treatment period in obese patients (BMI 30 to 45) with or without co-morbid conditions and overweight patients (BMI 27 to less than 30) with at least one co-morbid condition. The trial did not include dose titration or a run-in period. Patients were randomized at baseline in a 2:2:1 ratio to lorcaserin 10 mg twice daily, placebo or lorcaserin 10 mg once daily. Patients received echocardiograms at baseline, month 6 and at
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... March 27, 2015 /CNW/ - Covalon Technologies Ltd. (the ... company, today announced the issuance of an aggregate of ... Company and an aggregate of 120,500 stock options to ... will vest over three years and will be exercisable ... price of $1.40 per stock option. About ...
(Date:3/27/2015)... /PRNewswire/ - Medicure Inc. (the "Company") (TSXV:MPH, OTCQB:MCUJF) announces ... grant of an aggregate of 236,070 options to certain ... the Company pursuant to the Company,s Stock Option Plan. ... the tenth anniversary of the date of grant, 5,000 ... the date of grant and 50,000 are set to ...
(Date:3/27/2015)... , March 27, 2015  Holographic Optical Technologies ... the field of holographic medical imaging, is entering the ... Kickstarter campaign. Launching on April 20 th , 2015, ... Voxbox Pro. The 8-inch and 22-inch displays will allow ... for the first time. In addition to the two ...
Breaking Medicine Technology:Covalon Announces Issuance of Stock Options 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 3
... 23, 2011 Reportlinker.com announces that a new ... Global Medical Imaging Equipment ... This report analyzes the worldwide ... Million by the following Product segments: OEM (Original ...
... announces that a new market research report is available ... Kits and Trays Industry http://www.reportlinker.com/p090645/Global-Prepackaged-Medical-Kits-and-Trays-Industry.html ... markets for Prepackaged Medical Kits and Trays in US$ ... Ophthalmic Custom Trays, Custom or Basin Kits, Custom Ob/Gyn, ...
Cached Medicine Technology:Reportlinker Adds Global Medical Imaging Equipment Services Industry 2Reportlinker Adds Global Prepackaged Medical Kits and Trays Industry 2
(Date:3/28/2015)... (PRWEB) March 28, 2015 With ... in the fields of osteoporosis, osteoarthritis and musculoskeletal ... Osteoporosis, it may be the first time in ... research forum that the hot-button topic is an ... on the well-accepted scientific principles of Wolff’s law, ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Emergency Medical ... urgent care in Manhattan, recently commemorated its three-year anniversary ... in Manhattan. In addition to 24-hour urgent care, Emergency ... , At this time, Emergency Medical Care’s ... pain, asthma, chest pain, eye injuries, ear infections, fevers, ...
(Date:3/28/2015)... IL (PRWEB) March 28, 2015 Centurion Service ... equipment auction on Thursday, April 2 at their Las Vegas ... Vegas, NV 89081. The sale, which consists of equipment from ... begin promptly at 9 a.m. PDT. , Buyers will ... and surgery equipment. “We are a one-stop-shop,” said Erik Tivin, ...
(Date:3/28/2015)... Vegas, NV (PRWEB) March 28, 2015 ... injuries is a growing field in orthopaedic medicine. While ... labral tear to confirm the pain etiology, research presented ... ( AOSSM ) Specialty Day suggests that pain relief ... following arthroscopic hip surgery. , “Our study looked ...
(Date:3/28/2015)... 2015 Genomic medicine experts have sequenced ... for the first time, key information for understanding and ... the newly posted story on the Surviving Mesothelioma ... British Columbia, the British Columbia Cancer Agency, and PhenoPath ... underlying molecular alterations and mutations that can lead to ...
Breaking Medicine News(10 mins):Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Medical Equipment Auction to Take Place in North Las Vegas 2Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2
... the $60 billion international beauty products industry is ... a hundred cosmetics are in the Project on ... manufacturers as containing nanomaterials. , Critical to ... in their safety. In Europe, regulators and companies ...
... The rate of childhood,obesity in America has ... percent of children ages 10 to 17 are ... threat of the obesity epidemic for,children, families, communities ... a Healthy Florida ( http://www.bluefoundationfl.com ), the,philanthropic affiliate ...
... Joins 40 Others in Screening for Life-Threatening, Genetic,Disease, ... and the District of Columbia in requiring that all ... congratulate Alabama for initiating a newborn screening program for,cystic ... of the,Cystic Fibrosis Foundation. "More than 40 states are ...
... the Number of Women,s ... Medications Offered at a Discount, CINCINNATI, May 13 ... will expand their generic drug,program -- offering customers lower prices ... is offering 90-day prescriptions for,only $10 on its expanded generic ...
... Ancient acupuncture and modern myofascial pain therapy each focus ... treat pain, although they do it differently, says a ... two techniques. , Results of the study, published May ... suggest that people who want relief from chronic musculoskeletal ...
... New Retinoic Acid and Clindamycin Products Developed ... Skinvisible, Inc. (OTC,Bulletin Board: SKVI) ( ... on formulating enhanced patented dermatology,products, announced it ... Pharmaceutical Co. Ltd. ("Embil"). The Agreement is ...
Cached Medicine News:Health News:The Blue Foundation for a Healthy Florida Announces $8 Million Initiative to Address Childhood Obesity 2Health News:Alabama Begins Mandatory Screening of Newborns for Cystic Fibrosis 2Health News:Kroger and Its Family of Stores Expand Discounted Generic Drug Program 2Health News:Kroger and Its Family of Stores Expand Discounted Generic Drug Program 3Health News:Mayo Clinic study shows acupuncture and myofascial trigger therapy treat same pain areas 2Health News:Skinvisible Signs Licensing Agreement for Two Acne Formulations 2Health News:Skinvisible Signs Licensing Agreement for Two Acne Formulations 3
... comes with several blade sizes ... deep muscle retraction. The ... three different directions: medial, lateral ... optic light cable is compatible ...
Soft tissue shoulder retractor system...
Arthrex has the most extensive offering of arthroscopic suture passing instruments,available anywhere in the world. We have speci? cally designed the function of our,instruments to work hand in hand ...
The ArthroPasser easily passes any type of suture through tissue and its smooth jaw assists in eliminating,suture fraying....
Medicine Products: